Poor middle management, no hybrid work - Sr. Director AstraZeneca Employee Review

2.0
Jan 7, 2023
Recommend
CEO approval
Business Outlook

Pros

Executive management, Oncology portfolio, Salary, STI, LTI (Why I am still hanging out.)

Cons

Middle management (not moving on to give next generation an opportunity); non-Oncology portfolio; hiring/ promotion based on diversity stats, not qualification; no flexible work arrangements

Explore other reviews about AstraZeneca

5.0
Jul 23, 2026
Recommend
CEO approval
Business Outlook

Pros

Good flexibility and work life balance

Cons

Growth opportunity limited and can take years

5.0
Jul 20, 2026
Recommend
CEO approval
Business Outlook

Pros

Great work-life balance Cutting-edge science and technology Excellent research facilities Collaborative, multidisciplinary teams

Cons

Lower compensation than some competitors Slow promotions and career progression

See reviews by: Helpful|Rating|Date|All